1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst (LPA) Ryan Fulton conducted an unannounced subsequent visit to deliver findings regarding the above allegation. LPA was welcomed by, identified himself to, and discussed the purpose of the visit with Administrator Marko Kolomijcev. The Department's investigation consisted of LPA observations, interviews with facility staff, residents, and outside sources, as well as records reviews.
It was alleged that Licensee did not communicate with resident’s representative of change in medication. Specifically, it was reported that the Reporting Party had no knowledge of a medication change to R1’s medications list that now included Morphine. Records revealed that R1 was placed on hospice on 02/05/2024. This was confirmed by signatures on the Admissions Consent Agreement by R1’s responsible party. In this agreement, there is documentation describing what care the hospice agency provides, which includes a list of medication prescriptions that will be ordered on behalf of R1. One of the medications listed is Morphine, which comes in two different forms: one is a tab, and the other is liquid. |